Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Sabine Dressler, MD, Starke Martina, MD, Martin Wilhelm, MD PhD

Blood (2016) 128 (22): 5839.

https://doi.org/10.1182/blood.V128.22.5839.5839

Published: 2016

Journal Articles

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Barbara Pro, MD, Steven M. Horwitz, MD, H. Miles Prince, MB BS (Hons) MDFRACP FRCPA AFRACMA MACD, Francine M. Foss, MD, Lubomir Sokol, MD PhD, Matthew Greenwood, MD FRACP, FRCPA, Dolores Caballero, Franck Morschhauser, MD PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Prof, MD FACP, Swaminathan Padmanabhan Iyer, MD Dir, Hematological Malignancies, Andrei R. Shustov, MD, Julie Wolfson, MPH, Barbara E Balser, VMD, Bertrand Coiffier, MD PhD Prof

Blood (2014) 124 (21): 1742.

https://doi.org/10.1182/blood.V124.21.1742.1742

Published: 2014

Journal Articles

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Bettina Pilz, Michael Kramer, PhD, Gerhard Ehninger, MD, Martin Wilhelm, MD PhD, Hannes Wandt, MD

Blood (2014) 124 (21): 3686.

https://doi.org/10.1182/blood.V124.21.3686.3686

Published: 2014

Journal Articles

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, Miles Prince, MD, FRACP, FRCPA, Francine M. Foss, MD, Lubomir Sokol, MD, Ph.D, Matthew Greenwood, MD, FRACP, FRCPA, Dolores Caballero, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei R. Shustov, MD, Tina Nielsen, MD, PhD, Jean Nichols, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Steven M. Horwitz, MD

Blood (2012) 120 (21): 3641.

https://doi.org/10.1182/blood.V120.21.3641.3641

Published: 2012

Journal Articles

Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma

Bertrand Coiffier, MD, Barbara Pro, MD, H. Miles Prince, MBBS, FRACP, FRCPA, MD, Francine M. Foss, MD, Lubomir Sokol, MD, PhD, Matthew Greenwood, MD, FRCPA, FRACP, Dolores Caballero, MD, Peter Borchmann, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Swaminathan Padmanabhan, MBBS, MD, Andrei R. Shustov, MD, Jean Nichols, PhD, Susan Carroll, John Balser, PhD, Steven M. Horwitz, MD

Blood (2011) 118 (21): 591.

https://doi.org/10.1182/blood.V118.21.591.591

Published: 2011

Journal Articles

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Raoul Herbrecht, David MacDonald, MD, FRCPC, Florian Weissinger, MD, Martin Wilhelm, MD, Charles Holladay, MS, MD, Nam H. Dang, MD, PhD, Peter Holman, MD, Paul Cernohous, MS, Jack Singer, MD, Richard H. van der Jagt, MD, FRCPC

Blood (2011) 118 (21): 1605.

https://doi.org/10.1182/blood.V118.21.1605.1605

Published: 2011

Journal Articles

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, H. Miles Prince, MD, FRACP, FRCPA, Francine M Foss, MD, Lubomir Sokol, MD, PhD, Matthew Greenwood, MD, FRCPA, FRACP, Dolores Caballero, MD, Peter Borchmann, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei Shustov, MD, Jean Nichols, Susan Carroll, John Balser, PhD, Steven M Horwitz, MD

Blood (2010) 116 (21): 114.

https://doi.org/10.1182/blood.V116.21.114.114

Published: 2010

Journal Articles

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Martin Wilhelm, MD, PhD, U. Mahlknecht, MD, R. Conradi, MD, M. Schaich, MD, L. Leimer, MD, Hannes Wandt, MD

Blood (2006) 108 (11): 577.

https://doi.org/10.1182/blood.V108.11.577.577

Published: 2006

Journal Articles

Inhibition of γδ T Cell Proliferation by CD4 + CD25 + FOXP3 + Regulatory T Cells (Treg).

Volker Kunzmann, MD, Brigitte Kimmel, PhD, Judith Engert, Martin Wilhelm, MD, Hermann Einsele, MD

Blood (2006) 108 (11): 1742.

https://doi.org/10.1182/blood.V108.11.1742.1742

Published: 2006

Journal Articles

Clinical-Scale Combined CD4/CD8 Depletion for Donor Innate Lymphocyte Infusion (DILI).

Volker Kunzmann, MD, Manfred Smetak, PhD, Florian Weissinger, MD, Josef Birkmann, MD, Hermann Einsele, MD, Martin Wilhelm, MD

Blood (2006) 108 (11): 3657.

https://doi.org/10.1182/blood.V108.11.3657.3657

Published: 2006

Journal Articles

Routine Prophylactic Platelet Transfusions Are Not Necessary in Patients with Acute Myeloid Leukemia - A Therapeutic Transfusion Strategy Is Safe and Cost Effective.

Hannes Wandt, MD, Markus Frank, MD, Kerstin Schaefer-Eckart, MD, Martin Wilhelm, MD

Blood (2005) 106 (11): 428.

https://doi.org/10.1182/blood.V106.11.428.428

Published: 2005

Journal Articles

Multiple Myeloma as Target for γδ T Cell Mediated Immunotherapy - Expression of the Putative Vγ9Vδ2-TCR Ligand F1-ATPase on Myeloma Cells.

Volker Kunzmann, MD, Judith Engert, MS, Brigitte Kimmel, PhD, Martin Wilhelm, MD, Hermann Einsele, MD

Blood (2005) 106 (11): 3391.

https://doi.org/10.1182/blood.V106.11.3391.3391

Published: 2005

Journal Articles

γδ T Cell-Mediated Immunotherapy of Malignancies with Zoledronate and IL-2.

Volker Kunzmann, MD, Manfred Smetak, PhD, Brigitte Kimmel, PhD, Florian Weissinger, MD, Karin Weigang-Koehler, MD, Josef Birkmann, MD, Hermann Einsele, MD, Martin Wilhelm, MD

Blood (2005) 106 (11): 2439.

https://doi.org/10.1182/blood.V106.11.2439.2439

Published: 2005

Journal Articles

Superagonistic Anti-CD28 Antibody TGN1412 as a Potential Immunotherapeutic for the Treatment of B Cell Chronic Lymphocytic Leukemia.

Chia-Huey Lin, PhD, Thomas Kerkau, MD, Christine Guntermann, PhD, Martin Trischler, PhD, Niklas Beyersdorf, MD, Yvonne Scheuring, Hans-Peter Tony, MD, Christian Kneitz, MD, Martin Wilhelm, MD, Peter Mueller, PhD, Thomas Huenig, PhD, Thomas Hanke, PhD

Blood (2004) 104 (11): 2519.

https://doi.org/10.1182/blood.V104.11.2519.2519

Published: 2004

Journal Articles

Routine Prophylactic Platelet Transfusions Are Not Necessary for Patients in Clinically Stable Condition after Autologous Peripheral Stem Cell Transplantation(ASCT): Updated Results in 106 Patients.

Kerstin Schaefer-Eckart, MD, Markus Frank, MD, Martin Wilhelm, MD, Hannes Wandt, MD

Blood (2004) 104 (11): 3636.

https://doi.org/10.1182/blood.V104.11.3636.3636

Published: 2004

NARROW

Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma

CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

Final Results From a Pivotal, Multicenter, International, Open-Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

Inhibition of γδ T Cell Proliferation by CD4 + CD25 + FOXP3 + Regulatory T Cells (Treg).

Clinical-Scale Combined CD4/CD8 Depletion for Donor Innate Lymphocyte Infusion (DILI).

Routine Prophylactic Platelet Transfusions Are Not Necessary in Patients with Acute Myeloid Leukemia - A Therapeutic Transfusion Strategy Is Safe and Cost Effective.

Multiple Myeloma as Target for γδ T Cell Mediated Immunotherapy - Expression of the Putative Vγ9Vδ2-TCR Ligand F1-ATPase on Myeloma Cells.

γδ T Cell-Mediated Immunotherapy of Malignancies with Zoledronate and IL-2.

Superagonistic Anti-CD28 Antibody TGN1412 as a Potential Immunotherapeutic for the Treatment of B Cell Chronic Lymphocytic Leukemia.

Routine Prophylactic Platelet Transfusions Are Not Necessary for Patients in Clinically Stable Condition after Autologous Peripheral Stem Cell Transplantation(ASCT): Updated Results in 106 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only